Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)
VGFTe-RVO-1027
Phase 3 small_molecule completed
Quick answer
Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) for Branch Retinal Vein Occlusion is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Branch Retinal Vein Occlusion
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed